Literature DB >> 26730045

Use of Amnion Transfer in Resistant Nonhealing Venous Leg Ulcers.

Joseph Francis1, C R Shajimon1, A K Bhat2, B Kanakambaran1.   

Abstract

In the treatment of venous leg ulcers, after adopting many treatment modalities, at times we are still left with a local indolent problem, "the resistant nonhealing venous ulcer." With repeated surgical procedures failing to obtain a healed ulcer, constant pain, persistent discharging wound, infections, etc., many a patient turn hostile. Also, there comes a dimension of despair in the health feeling of the patient. This prospective study was conducted in 40 patients, who were within the inclusion criteria (January 2006-January 2010, 12 males and 28 females, mean age 45 years). A single amniotic membrane (AM) transfer was done after preparation of the wound, and the parameters were assessed periodically. Follow-up for a minimum period of 1 year in all cases and a maximum period of 3 years in many cases (38) was done. Significant clinical response was defined as an ulcer healing greater than 75 % of the original area. Treatment failure was taken as a persistence or recurrence of more than 25 % of the ulcer area in a 1-year follow-up period. The preliminary results of good ulcer healing and no recurrence are encouraging, even up to 3-year follow-up. This proof-of-concept study demonstrates that AM transfer is useful, safe, inexpensive, readily available, and well accepted by patients, with tremendous potential in promoting epithelial healing in "the resistant nonhealing chronic venous leg ulcer."

Entities:  

Keywords:  AM transfer; Epithelization; Healing; Recurrence; Resistant nonhealing venous ulcers; Wound infection

Year:  2013        PMID: 26730045      PMCID: PMC4692879          DOI: 10.1007/s12262-013-0875-7

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  17 in total

Review 1.  Amnion-derived pluripotent/multipotent stem cells.

Authors:  Toshio Miki; Stephen C Strom
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

2.  Current management of venous ulceration.

Authors:  Nima P Patel; Nicos Labropoulos; Peter J Pappas
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

3.  Aetiology of chronic leg ulcers.

Authors:  S R Baker; M C Stacey; G Singh; S E Hoskin; P J Thompson
Journal:  Eur J Vasc Surg       Date:  1992-05

4.  Use of amniotic membrane in dermatology.

Authors:  Annamma John; John Oommen
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Mar-Apr       Impact factor: 2.545

5.  Human amniotic membrane as a physiologic wound dressing.

Authors:  G Colocho; W P Graham; A E Greene; D W Matheson; D Lynch
Journal:  Arch Surg       Date:  1974-09

6.  Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua.

Authors:  Keith W Marvin; Jeffrey A Keelan; Roberta L Eykholt; Timothy A Sato; Murray D Mitchell
Journal:  Am J Obstet Gynecol       Date:  2002-09       Impact factor: 8.661

Review 7.  The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues.

Authors:  Ayaka Toda; Motonori Okabe; Toshiko Yoshida; Toshio Nikaido
Journal:  J Pharmacol Sci       Date:  2007-11-06       Impact factor: 3.337

8.  Human amnion in the treatment of chronic ulceration of the legs.

Authors:  A Shun; G Ramsey-Stewart
Journal:  Med J Aust       Date:  1983-09-17       Impact factor: 7.738

9.  Use of amniotic membrane transplantation in the treatment of venous leg ulcers.

Authors:  Isabelle Mermet; Nathalie Pottier; Jean Marie Sainthillier; Carole Malugani; Sandrive Cairey-Remonnay; Stéphane Maddens; Didier Riethmuller; Pierre Tiberghien; Philippe Humbert; François Aubin
Journal:  Wound Repair Regen       Date:  2007 Jul-Aug       Impact factor: 3.617

10.  Human amnion in the management of chronic ulceration of the lower limb: a clinico-pathologic study.

Authors:  T J Egan; J O'Driscoll; D R Thakar
Journal:  Angiology       Date:  1983-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.